Search Tag: rare diseases
2024 25 Sep
September is MPN Awareness Month. These four weeks are dedicated to a group of rare blood cancers called myeloproliferative neoplasms (MPN) and meant to put an emphasis on the challenges faced by patients affected. The Austrian pharmaceutical company AOP Orphan Pharmaceuticals GmbH (AOP Health), specializing in the research and development of...Read more
2024 25 Sep
On Tuesday 24 September, Alexander Natz, Secretary General of the European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE), sent a letter to the President of the European Commission Ursula von der Leyen, President of the European Parliament Roberta Metsola, and President of the European Council Charles Michel, outlining our vision for...Read more
2024 21 May
Launch of 20 new medicines expected by 2030 Significant growth from existing oncology, biopharmaceuticals and rare disease portfolios Investing in disruptive innovation that will shape the future of medicine and drive long-term growth Decoupling carbon emissions from revenue growth AstraZeneca revealed its bold ambition to deliver...Read more
2024 21 May
Launch of 20 new medicines expected by 2030 Significant growth from existing oncology, biopharmaceuticals and rare disease portfolios Investing in disruptive innovation that will shape the future of medicine and drive long-term growth Decoupling carbon emissions from revenue growth AstraZeneca revealed its bold ambition to deliver...Read more